Haemonetics (HAE) Q1 Earnings Miss Estimates, Gross Margin Rises [Yahoo! Finance]
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: Yahoo! Finance
The bottom line missed the Zacks Consensus Estimate by 0.9%. On a GAAP basis, the EPS was 74 cents compared with 80 cents in the prior-year quarter. Total Revenues Revenues increased 8% (up 2.8% on an organic basis) to $336.2 million in the first quarter of fiscal 2025. The top line beat the Zacks Consensus Estimate by 0.1%. Segments in Detail At Plasma , revenues of $135.9 million (accounting for 40.4% of the total revenues) were down 2.7% year over year (down 2.6% on an organic basis) in the reported quarter. Our model projected the unit's revenues to be $131.8 million. The decrease resulted from lower sales volumes in North America relating to a previously announced customer transition and a temporary plasma center outage at one of the company's customers. Haemonetics Corporation Price, Consensus and EPS Surprise Haemonetics Corporation price-consensus-eps-surprise-chart | Haemonetics Corporation Quote Revenues at Blood Center (19.7%) fell 4.3% (down 2.1% on an or
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024PR Newswire
- Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.MarketBeat
- Is Haemonetics Corporation (HAE) an Undervalued Healthcare Stock to Buy in 2025 [Yahoo! Finance]Yahoo! Finance
- Haemonetics Co. (NYSE: HAE) is now covered by analysts at CL King. They set a "buy" rating and a $116.00 price target on the stock.MarketBeat
- Haemonetics Co. (NYSE: HAE) is now covered by analysts at Bank of America Co.. They set a "neutral" rating and a $85.00 price target on the stock.MarketBeat
HAE
Earnings
- 8/9/24 - Miss
HAE
Sec Filings
- 11/5/24 - Form 4
- 9/18/24 - Form 4
- 9/16/24 - Form 8-K
- HAE's page on the SEC website